Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis

被引:5
作者
Kroshian, Garen [1 ]
Joseph, Jacob [2 ,3 ,4 ]
Kinlay, Scott [1 ,4 ,5 ,6 ]
Peralta, Adelqui O. [1 ,4 ,5 ]
Hoffmeister, Peter S. [1 ,4 ,5 ]
Singh, Jagmeet P. [5 ,7 ]
Yuyun, Matthew F. [1 ,4 ,5 ,8 ]
机构
[1] Boston Univ, Chobanian & Avedisian Sch Med, Boston, MA USA
[2] VA Providence Healthcare Syst, Providence, RI USA
[3] Brown Univ, Dept Med, Providence, RI USA
[4] VA Boston Healthcare Syst, Boston, MA USA
[5] Harvard Med Sch, Boston, MA USA
[6] Brigham & Womens Hosp, Boston, MA USA
[7] Massachusetts Gen Hosp, Boston, MA USA
[8] Cardiol & Vasc Med Serv, VA Boston Healthcare Syst, 1400 VFW Pkwy, West Roxbury, MA 02132 USA
关键词
atrial fibrillation; ejection fraction; heart failure; mortality; PROGNOSTIC-SIGNIFICANCE; MYOCARDIAL-INFARCTION; CATHETER ABLATION; MIDRANGE; ASSOCIATION; MORTALITY; READMISSIONS; BORDERLINE;
D O I
10.1111/jce.16209
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionHeart failure (HF) and atrial fibrillation (AF) frequently co-exist. Contemporary classification of HF categorizes it into HF with reduced ejection fraction (HFrEF), HF with mildly reduced ejection fraction (HFmrEF), and HF with preserved ejection fraction (HFpEF). Aggregate data comparing the risk profile of AF between these three HF categories are lacking.MethodsWe conducted a systematic review and meta-analysis aimed at determining any significant differences in AF-associated all-cause mortality, HF hospitalizations, cardiovascular mortality (CV), and stroke between HFrEF, HFmrEF, and HFpEF. A systematic search of PubMed, EMBASE, and Cochrane Library databases until February 28, 2023. Data were combined using DerSimonian-Laird random effects model.ResultsA total of 22 studies comprising 248 323 patients were retained: HFrEF 123 331 (49.7%), HFmrEF 40 995 (16.5%), and HFpEF 83 997 (33.8%). Pooled baseline AF prevalence was 36% total population, 30% HFrEF, 36% HFmrEF, and 42% HFpEF. AF was associated with a higher risk of all-cause mortality in the total population with pooled hazard ratio (HR) = 1.13 (95% confidence interval [CI] = 1.07-1.21), HFmrEF (HR = 1.25, 95% CI = 1.05-1.50) and HFpEF (HR = 1.16, 95% CI = 1.09-1.24), but not HFrEF (HR = 1.03, 95% CI = 0.93-1.14). AF was associated with a higher risk of HF hospitalizations in the total population (HR = 1.29, 95% CI = 1.14-1.46), HFmrEF (HR = 1.64, 95% CI = 1.20-2.24), and HFpEF (HR = 1.46, 95% CI = 1.17-1.83), but not HFrEF (HR = 1.01, 95% CI = 0.87-1.18). AF was only associated with CV in the HFpEF subcategory but was associated with stroke in all three HF subtypes.ConclusionsAF appears to be associated with a higher risk of all-cause mortality and HF hospitalization in HFmrEF and HFpEF. With these findings, the paucity of data and treatment guidelines on AF in the HFmrEF subgroup becomes even more significant and warrant further investigations.
引用
收藏
页码:715 / 726
页数:12
相关论文
共 68 条
[1]   Meta-analysis of the Usefulness of Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure With Preserved Ejection Fraction [J].
Aldaas, Omar M. ;
Lupercio, Florentino ;
Darden, Douglas ;
Mylavarapu, Praneet S. ;
Malladi, Chaitanya L. ;
Han, Frederick T. ;
Hoffmayer, Kurt S. ;
Krummen, David ;
Ho, Gordon ;
Raissi, Farshad ;
Birgersdotter-Green, Ulrika ;
Feld, Gregory K. ;
Hsu, Jonathan C. .
AMERICAN JOURNAL OF CARDIOLOGY, 2021, 142 :66-73
[2]   Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials [J].
AlTurki, Ahmed ;
Proietti, Riccardo ;
Dawas, Ahmed ;
Alturki, Hasan ;
Thao Huynh ;
Essebag, Vidal .
BMC CARDIOVASCULAR DISORDERS, 2019, 19 (1)
[3]   Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: A nationwide cohort study of 9519 patients [J].
Andersson, Tommy ;
Magnuson, Anders ;
Bryngelsson, Ing-Liss ;
Frobert, Ole ;
Henriksson, Karin M. ;
Edvardsson, Nils ;
Poci, Dritan .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 177 (01) :91-99
[4]   Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis [J].
Androulakis, Emmanuel ;
Sohrabi, Catrin ;
Briasoulis, Alexandros ;
Bakogiannis, Constantinos ;
Saberwal, Bunny ;
Siasos, Gerasimos ;
Tousoulis, Dimitris ;
Ahsan, Syed ;
Papageorgiou, Nikolaos .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (02)
[5]  
Heidenreich Paul A, 2022, Circulation, V145, pe895, DOI [10.1161/CIR.0000000000001073, 10.1161/CIR.0000000000001063]
[6]   Atrial Fibrillation and Heart Failure Treatment Considerations for a Dual Epidemic [J].
Anter, Elad ;
Jessup, Mariell ;
Callans, David J. .
CIRCULATION, 2009, 119 (18) :2516-2525
[7]  
Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI [10.1161/CIR.0000000000000746, 10.1161/CIR.0000000000000659]
[8]   Clinical characteristics and prognosis of patients admitted for heart failure: A 5-year retrospective study of African patients [J].
Bonsu, Kwadwo Osei ;
Owusu, Isaac Kofi ;
Buabeng, Kwame Ohene ;
Reidpath, Daniel D. ;
Kadirvelu, Amudha .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 238 :128-135
[9]   The Universal Definition of Heart Failure: Perspectives from Diverse Stakeholders [J].
Mentz, Robert J. ;
Lala, Anuradha .
JOURNAL OF CARDIAC FAILURE, 2021, 27 (04) :386-386
[10]   Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort [J].
Chen, Shiqun ;
Huang, Zhidong ;
Liang, Yan ;
Zhao, Xiaoli ;
Aobuliksimu, Xiemuxikaimaier ;
Wang, Bo ;
He, Yibo ;
Kang, Yu ;
Huang, Haozhang ;
Li, Qiang ;
Yao, Younan ;
Lu, Xiaozhao ;
Qian, Xiaoxian ;
Xie, Xujing ;
Liu, Jin ;
Liu, Yong .
ESC HEART FAILURE, 2022, 9 (04) :2336-2347